Michael Rice - 30 Oct 2023 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Reporting relationship: Former CEO and Director
Issuer ticker: BLFS
Reported as of: 30 Oct 2023
Net transaction value: -$662,865
SEC form: 4
Accepted by SEC: 01 Nov 2023, 17:30:03 UTC
Prior SEC filing: 24 Oct 2023
Source filing: View source filing
Reporting owner signature: /s/ Michael Rice

Key filing fact

Michael Rice filed Form 4 for BIOLIFE SOLUTIONS INC (BLFS) on 01 Nov 2023.

Key facts

This page summarizes Michael Rice's Form 4 filing for BIOLIFE SOLUTIONS INC (BLFS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 01 Nov 2023, 17:30.

Change

Previous filing in this sequence was filed on 24 Oct 2023.
Current net transaction value: -$662,865.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLFS transaction

Common Stock

Sale

Transaction value: $662,865
Shares: -72,603
Change %: -17%
Price: $9.13
Shares after: 347,085
Date: 30 Oct 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Michael Rice is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The sale reported herein was made pursuant to Rule 10b5-1 (c) trading plans adopted by the reporting person effective as of 03-25-2020, 02-08-21, 02-24-2022, and 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.